StonvexLoading…
StonvexStonvexStonvexCore line items from RYZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.57B | $4.60B | $5.11B | $6.32B |
Operating Income | $-30.80M | $31.50M | $228.10M | $578.70M |
Net Income | $-56.40M | $-8.60M | $145.70M | $391.00M |
EPS (Diluted) | $-1.76 | $-0.26 | $4.10 | $10.21 |
Total Assets | $2.40B | $2.44B | $2.57B | $2.33B |
Total Liabilities | $1.64B | $1.61B | $1.66B | $1.44B |
Cash & Equivalents | $26.90M | $27.70M | $54.30M | $39.20M |
Free Cash Flow OCF − CapEx | $35.50M | $105.30M | $243.20M | $396.10M |
Shares Outstanding | 32.12M | 33.19M | 35.57M | 38.28M |